Five things for pharma marketers to know: Thursday, July 26, 2018

Alzheimer's drug slows cognitive decline; Gilead CEO to leave; Amgen migraine drug face difficulties with insurers.

from Most popular articles from Medical Marketing and Media https://ift.tt/2vaMorc